Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
- PMID: 25242166
- PMCID: PMC4686233
- DOI: 10.1042/BJ20140772
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain
Abstract
Accumulation of oxidative damage is a common feature of neurodegeneration that, together with mitochondrial dysfunction, point to the fact that reactive oxygen species are major contributors to loss of neuronal homoeostasis and cell death. Among several targets of oxidative stress, free-radical-mediated damage to proteins is particularly important in aging and age-related neurodegenerative diseases. In the majority of cases, oxidative-stress-mediated post-translational modifications cause non-reversible modifications of protein structure that consistently lead to impaired function. Redox proteomics methods are powerful tools to unravel the complexity of neurodegeneration, by identifying brain proteins with oxidative post-translational modifications that are detrimental for protein function. The present review discusses the current literature showing evidence of impaired pathways linked to oxidative stress possibly involved in the neurodegenerative process leading to the development of Alzheimer-like dementia. In particular, we focus attention on dysregulated pathways that underlie neurodegeneration in both aging adults with DS (Down's syndrome) and AD (Alzheimer's disease). Since AD pathology is age-dependent in DS and shows similarities with AD, identification of common oxidized proteins by redox proteomics in both DS and AD can improve our understanding of the overlapping mechanisms that lead from normal aging to development of AD. The most relevant proteomics findings highlight that disturbance of protein homoeostasis and energy production are central mechanisms of neurodegeneration and overlap in aging DS and AD. Protein oxidation affects crucial intracellular functions and may be considered a 'leitmotif' of degenerating neurons. Therapeutic strategies aimed at preventing/reducing multiple components of processes leading to accumulation of oxidative damage will be critical in future studies.
Figures
Similar articles
-
Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.Free Radic Biol Med. 2014 Jun;71:270-280. doi: 10.1016/j.freeradbiomed.2014.03.027. Epub 2014 Mar 25. Free Radic Biol Med. 2014. PMID: 24675226 Free PMC article.
-
Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.Proteomics Clin Appl. 2014 Feb;8(1-2):73-85. doi: 10.1002/prca.201300066. Proteomics Clin Appl. 2014. PMID: 24259517 Free PMC article. Review.
-
ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.J Neurosci. 2005 Mar 2;25(9):2295-303. doi: 10.1523/JNEUROSCI.5107-04.2005. J Neurosci. 2005. PMID: 15745955 Free PMC article.
-
HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.Free Radic Biol Med. 2017 Oct;111:262-269. doi: 10.1016/j.freeradbiomed.2016.10.508. Epub 2016 Nov 10. Free Radic Biol Med. 2017. PMID: 27838436 Free PMC article. Review.
-
Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2021-37. doi: 10.1089/ars.2006.8.2021. Antioxid Redox Signal. 2006. PMID: 17034347 Review.
Cited by
-
The neuropathology and cerebrovascular mechanisms of dementia.J Cereb Blood Flow Metab. 2016 Jan;36(1):172-86. doi: 10.1038/jcbfm.2015.164. J Cereb Blood Flow Metab. 2016. PMID: 26174330 Free PMC article. Review.
-
Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview.Molecules. 2021 May 24;26(11):3139. doi: 10.3390/molecules26113139. Molecules. 2021. PMID: 34073948 Free PMC article. Review.
-
Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach.J Med Genet. 2020 May;57(5):289-295. doi: 10.1136/jmedgenet-2019-106277. Epub 2019 Nov 8. J Med Genet. 2020. PMID: 31704779 Free PMC article. Review.
-
Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update.Int J Mol Sci. 2022 May 16;23(10):5574. doi: 10.3390/ijms23105574. Int J Mol Sci. 2022. PMID: 35628384 Free PMC article. Review.
-
Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).J Neurosci. 2019 Jul 3;39(27):5255-5268. doi: 10.1523/JNEUROSCI.0578-19.2019. Epub 2019 May 1. J Neurosci. 2019. PMID: 31043483 Free PMC article.
References
-
- Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991;91:14S–22S. - PubMed
-
- Hansford RG, Hogue BA, Mildaziene V. Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomembr. 1997;29:89–95. - PubMed
-
- Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life. 2001;52:159–164. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical